# Immunogenic Cell Death as a Novel Mechanism of Mitomycin C Activity in Bladder Cancer

> **NCT04256616** · — · UNKNOWN · sponsor: **Istituto Clinico Humanitas** · enrollment: 110 (estimated)

## Conditions studied

- Bladder Cancer

## Interventions

- **OTHER:** This is an observational study that does not concern a direct intervention on patients and control subjects and does not interfere with the clinical management of patients.

## Key facts

- **NCT ID:** NCT04256616
- **Lead sponsor:** Istituto Clinico Humanitas
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-06-27
- **Primary completion:** 2020-09-01
- **Final completion:** 2020-09-30
- **Target enrollment:** 110 (ESTIMATED)
- **Last updated:** 2020-07-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04256616

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04256616, "Immunogenic Cell Death as a Novel Mechanism of Mitomycin C Activity in Bladder Cancer". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT04256616. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*